Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-23

Clinical Trial Update: Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity and safety of co-administering the DPT-IPV vaccine with Rotarix in healthy infants; study completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DPT-IPV vaccine Squarekids
  • Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rotavirus | Phase 4 | Status: COMPLETED | Results posted: 2019-01-23